Reply to “Statins may decrease the Fatality Rate of MERS Infection”
Open Access
- 30 October 2015
- journal article
- Published by American Society for Microbiology in mBio
- Vol. 6 (5) , e01303-15-15
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- Statins May Decrease the Fatality Rate of Middle East Respiratory Syndrome InfectionmBio, 2015
- Toll-Like Receptor 3 Signaling via TRIF Contributes to a Protective Innate Immune Response to Severe Acute Respiratory Syndrome Coronavirus InfectionmBio, 2015
- Pre- and postexposure efficacy of fully human antibodies against Spike protein in a novel humanized mouse model of MERS-CoV infectionProceedings of the National Academy of Sciences, 2015
- Inhibition of NF-κB-Mediated Inflammation in Severe Acute Respiratory Syndrome Coronavirus-Infected Mice Increases SurvivalJournal of Virology, 2014
- A Strategy To Estimate Unknown Viral Diversity in MammalsmBio, 2013
- Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptorNature, 2013
- Molecular Determinants of Severe Acute Respiratory Syndrome Coronavirus Pathogenesis and Virulence in Young and Aged Mouse Models of Human DiseaseJournal of Virology, 2012
- MyD88 Is Required for Protection from Lethal Infection with a Mouse-Adapted SARS-CoVPLOS Pathogens, 2008
- Interferon-Mediated Immunopathological Events Are Associated with Atypical Innate and Adaptive Immune Responses in Patients with Severe Acute Respiratory SyndromeJournal of Virology, 2007
- SARS: Systematic Review of Treatment EffectsPLOS Medicine, 2006